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The majority of known compounds produced by these bacteria are the products of biosynthetic mega enzymes termed polyketide synthases (PKSs) and non ribosomal peptide synthetases (NRPSs). The assembly of monomeric organicand amino acids building blocks via mixed PKS-NRPS systems results in the formation of hybrid PKS-NRPS compounds exhibiting enomerous structural complexity. End products of PKS and (or) NRPS megasynthases are usually modified by dedicated tailoring enzymes which attain internal conformation, eventually increase the degree of compound diversity and often establish biological activity. These reactions may occur on a framework of growing acyl-S-enzyme intermediates and are usually mediated by enzymes which are integrated into the biosynthetic megasynthetases themselves (2;3). In addition, the natural products may undergo post assembly modifications, catalyzed in trans by dedicated enzymes to yield the final structures (4) (5) (6) (7) . Enzymatic decarboxylations are widespread in nature. The reaction is known to occur through a variety of mechanisms that modify specific substrates (8;9) . Dependent of their catalytic cofactor, decarboxylases are categorized in two major classes. The first class utilizes organic cofactors such as biotin, flavin and NAD + /NADP + (10) (11) (12) , and the second class of decarboxylases require inorganic cofactors (13) . Recently, a third enzyme class was identified which performs decarboxylation without a known cofactor (8;14) . Molecular and biochemical studies of natural product biosynthesis have revealed the essential role of decarboxylases in generating structural diversity, in some cases during the maturation of secondary metabolites. One example of these enzymes is the decarboxylase that is encoded in the biosynthetic pathway of the potent lipopeptide antibiotic barbamide in the marine cyanobacterium Lyngbya majuscula. According to the proposed biosynthetic scheme, a carrier protein-bound 4-carboxy-thiazoline intermediate is presumed to be released by the thioesterase domain of BarG and then undergo a final decarboxylation to give the thiazole system of the end product. Interestingly, no oxidative domain is found in the respective module of the terminal NRPS protein, BarG. Therefore, it was postulated that BarJ, which is encoded downstream of the gene cluster might play a role in the oxidative decarboxylation step to create the thiazole ring of the end product (15;16) . Moreover, the biologically active long chain Nacyl aromatic amino acids, eneamides and their enol esters have been isolated after heterologous expression of environmental DNA (feeA-feeM) in E. coli (17) . Formation of the amide is thought to be catalyzed by an N-acyl synthase that couples free tyrosine to an activated long chain fatty acid, delivered by an acyl carrier protein (ACP) of the Fee assembly system. It has been shown that inactivation of a putative flavoprotein oxidase (FeeG) of the fee gene cluster mediates accumulation of an N-acyltyrosine intermediate. From this evidence, FeeG was proposed to catalyze styryl moiety formation by oxidative decarboxylation (18) The chondrochloren biosynthetic pathway possesses several highly unusual and intriguing features, including biochemical transformations which are rarely found in other bacterial secondary metabolite biosyntheses. This includes an early chlorination of the tyrosine moiety and the formation of an ethoxy moiety in chondrochloren B which is performed by a radical SAM dependent protein methylating a non reactive carbon center in chondrochloren A. Another unusual feature in this compound class is the unusual hydroxyl-styryl functionality at the terminus of the structure. We hypothesized that the final step in the biosynthesis of chondrochloren, like in eneamide biosynthesis, would be an oxidative decarboxylation of a functionalized tyrosine, to yield both chondrochlorens A and B (Figure 1 ). Here, we report the inactivation of cndG in the chondrochloren gene cluster which resulted in the accumulation of carboxylated chondrochlorens A and B (pre-chondrochlorens), biosynthetic intermediates which are shown to be the substrates of CndG. We cloned and biochemically characterized CndG and show this enzyme to be a novel catalyst for the oxidative decarboxylation of biologically inactive pre-chondrochloren. These results provide insights into the post-assembly modulation of pre-chondrochloren and its maturation into the final chondrochloren antibiotic.
EXPERIMENTAL PROCEDURES
General molecular biological methods -Standard methods for DNA isolation and manipulation were used (19;20) . DNA fragments were isolated from agarose gels using the NucleoSpin Extract gel extraction kit (Machery-Nagel, Düren, Germany Inactivation of cndG -An internal fragment of the cndG gene containing a frameshift at the 5′-end, was amplified using oligos Cnd-decar-frameup (5′-GAT CTT CTG ACT TCC GCC TC-3′) (the mutagenic base pair is indicated in italics) and Cnd-decar-dn (5′-CAG CTC TCG GTC GTA CAT-3′). The PCR product was cloned into pCR2.1TOPO for sequencing creating pTOPOCndG. After sequence verification, the insert was excised as an EcoRV/HindIII fragment and subcloned into vector pSUPHyg to generate plasmid pSR13. pSR13 was introduced into cells of E. coli ET12567 carrying pUB307 for biparental mating with C. crocatus Cm c5 by conjugation as described previously (21) . Mutants were selected on Pol03 agar supplemented with 100 µg ml -1 hygromycin and 120 µg ml -1 tobramycin. Correct integration of the vector into genome and thus disruption of the gene were confirmed by PCR analysis using primers PSUP-EV and FAD-XhoIdn (5′-CCT CGA GTC AGT TGT CCG CGG GCG-3′), or FAD-EcoRI-up (5′-GGA ATT CAT GAA CAC ACA GCC CCT GGA-3′) and FADXhoI-dn, using genomic DNA of three isogenic Cmc-cndG -mutants in comparison to the C. Purification of the pre-chondrochloren BMutant Cmc-cndG -was grown in Pol03 medium supplemented with 100 µg ml -1 hygromycin in the presence of 1% Adsorber-Harz (XAD 16) resin. Methanolic extracts of the resin were applied to a Sephadex LH-20 column (GE Healthcare), with methanol as solvent. Fractions (7 mL) containing pre-chondrochlorens A and B were identified by HPLC-MS, and combined. The prechondrochloren B was obtained at high purity by HPLC in two steps using a Zorbax C8 column.
Step 1: solvent: water (A)/acetonitrile (B) containing 0.1% formic acid; gradient 45% B for 7.5 min, 2.5 min to 60% B, 6 min to 95% B; flow rate: 6 mL min -1 .
Step 2: solvent: water (A)/acetonitrile (B), gradient: 20-50% B for 8.5 min, then to 95% B in 1.5 min; flow rate: 3.6 mL min -1 . After purification, the biological activity of the compound in comparison to chondrochloren B was analysed by using an antibiogram agar diffusion assay employing 6 mm filter paper discs saturated with 30 µg of the compounds and subsequent growth inhibition assaying of Micrococcus luteus, and Bacillus subtilis.
Expression and purification of recombinant CndG -cndG was amplified from chromosomal DNA of C. crocatus Cm c5 using primers FADEcoRI-up and FAD-XhoI-dn. The resulting product (1639 bp) was cloned into pCR2.1TOPO for sequencing, and then sub-cloned into the expression vector pGEX-6P-1 (Invitrogen). The resulting construct, pGEX-CndG, was transformed into E. coli BL21 cells for protein expression. The cells were grown in LB medium containing 100 µg ml -1 ampicillin at 37 °C until an OD 600 of 0.6 was reached, and then protein expression was induced with 0.1 mM IPTG and growth was continued at 16 °C overnight. Cells were harvested by centrifugation and disrupted by French Press at 4°C in 1 phosphate buffered saline (PBS). Cell debris was removed by centrifugation at 25,000  g. The supernatant was bound to a MicroSpin TM GST purification module, washed twice with 10 volume 1 PBS buffer, and then the pure CndG released by cleavage with PreScission Protease (Amersham Biosciences) at 4 °C in cleavage buffer, according to the manufacturer's instructions. The molecular weight of the protein obtained was confirmed by MALDI mass spectrometry.
Enzymatic activity of the CndG -Activity assays of the CndG (0.2 µM) was carried out in buffer (50 mM Tris-HCl (pH 6.0), containing 10 µM prechondrochloren and 100 µM FAD. Control reaction was performed in parallel without addition of the enzyme. The reactions were incubated at 30 °C, for various time points (5, 10, 30 min), followed by quenching with 1 µl TFA. Methanol (80 µL) was added to each aliquot, centrifuged and then the samples analyzed using a Bruker HCT plus mass spectrometer. For analysis of co-factor binding, CndG (50 µg; 0.83 nmol) was denaturated at 100°C for 10 minutes to free the flavin cofactor, and then the mixture was centrifuged at 16,060  g for 20 minutes at 4 C. The supernatant was lyophilized and the pellet resuspended in 20% methanol, and then subjected to HPLC-MS relative to a commercial sample of FAD. The effect of FMN as alternative cofactor was tested either by addition of both FAD and FMN into the reaction, or addition of FMN alone. To study the effect of the tag on the enzyme activity, reactions were done using purified NusA-tagged and GST-tagged protein. To study the effect of metals, Zn , and Fe 2+ at 0.1 mM was added into the enzyme reaction. Effect of metal chelators on CndG activity was determined by addition of 2.5 mM EDTA or/and EGTA into to the reaction and control reactions were carried out in parallel under standard conditions. Identification of the pH optimum of the enzyme reaction was done using Tris-HCl buffer (50 mM, pH 4.0 to 9.0) under standard conditions. All reactions were performed in triplicate. The CndG activity was estimated according to the amount of the resulted product (chondrochloren B). Concentration of the chondrochloren B was quantified based on the analysis of the characteristic fragment ion (R t = 12.0 min, m/z [M+H] + = 434.1), using a Zorbax C8 column: solvent: water (A)/acetonitrile (B) containing 0.1% formic acid; 0-0.5 min 45% B; 0.5-2 min linear from 45% to 55% B; 2-11 min isocratic at 55% B; 11-12 min linear from 55% to 95% B; 12-13 min isocratic at 95% B, and then 13-14 min linear from 95% to 45% B. A calibration curve based on the chondrochloren B reference standard was built and used to compare the concentration of the product in the samples. All reactions were performed in triplicates. For comparison of CndG activity under aerobic and anaerobic conditions, buffer (50 mM Tris-HCl) was purged of oxygen using oxygen-free nitrogen, overnight at 30 C. Buffer (100 µL) containing pre-chondrochlorens B (10 µM) or a mixture of pre-chondrochloren A and B, 100 µM FAD, and 0.2 µM CndG was then added. The "anaerobic" reaction was covered with mineral oil (100 µL), incubated for 2 h at 30 C, and then quenched by addition of methanol (100 µL). A control reaction was carried out in parallel under standard conditions. Each assay was repeated in triplicates, and results were analyzed by HPLC-MS. To test substrate specificity of the enzyme, in addition to L-tyrosine and 3-chloro-tyrosine, various N-acyl-L-tyrosine and meta-chloro-tyrosine Figure 1) . CndG is essential for chondrochloren biosynthesis -To evaluate our proposal for generation of the styryl moiety and involvement of CndG as a key enzyme for maturation of the metabolite, we aimed to inactivate the cndG gene in the Cm c5 strain. The experiment was achieved via homologous recombination of the cndG inactivation plasmid into the bacterial genome (Figure 2a) . Verification of the resulting mutants Cmc-cndG -was achieved by PCR amplification of the inserted fragment. A 1016 bp PCR product was generated by the use of the oligonucleotides PSUP-EV and FAD-XhoI-dn, and the genomic DNA of the mutants Cmc-cndG -, whereas no PCR fragment was generated from the wild type DNA under these conditions. In addition, a 1639 bp PCR product covering the whole cndG sequence was generated by the use of FAD-EcoRI-up and FADXhoI-dn primers from the genomic DNA of the wild type only, confirming disruption of the cndG (Figure 2b ). This result, in combination with hygromycin resistance of the mutants clearly shows plasmid integration into the correct position of the bacterial genome. Consequently, a frame shift mutation was introduced into the first copy of cndG, and the second copy is promoterless ( Figure  2a ). After fermentation of the mutants and the wild type in Pol03 medium with XAD, no difference in growth of the mutants was observed in comparison to the wild type. Methanolic extracts from cultures of the wild type and the Cmc-cndG -mutants were analyzed by HPLC-MS showing abolishment of chondrochloren production in the mutants (Figure  2c and d) . By careful search for chondrochloren production in the mutant extracts, we could, however, identify two new products differing from chondrochlorens A or B by 46 mass units ( Figure  3 ). High resolution mass spectrometry (HRMS), as well as MS/MS fragmentation data of the new compounds suggested the compounds to be two isomers of pre-chondrochloren A C 28 Figure  3a) . Structure elucidation of Pre-chondrochloren BTo confirm our hypothesis concerning the chondrochloren biosynthetic intermediates, the most abundant pre-chondrochloren B 4 was purified from 10 L culture of the Cmc-cndG -mutant, and its identity was confirmed by 2D NMR (Figure 4) . The spectra of the purified compound were recorded on a Bruker Advance 500 instrument at 500 MHz. The spectra were assigned by comparison with the published data for chondrochloren B (22) , which showed significant differences in the signals corresponding to 1′-H and 2′-H, as well as the appearance of a new carbon signal (δ C = 170.8) ( Table 1) . 1 H, 13 C-HMBC analysis revealed that the new carbon is located adjacent to 1′-H (Figure 4 , and Fe 2+ resulted in no significant change in the observed enzyme activity.
We also directly compared decarboxylation by CndG under aerobic and anaerobic conditions. Under low oxygen conditions, production of chondrochloren B was essentially undetectable, while decarboxylation to chondrochloren A was reduced by approximately 95% (Figure 6a and b) . To test the substrate specificity of CndG various N-acyl derivatives of L-tyrosine 7a-e and 3-chloro-L-tyrosine 9a-e were synthesized (Supplementary methods). The selective N-acylation of L-tyrosine was easily achieved through refluxing with stoichiometric amounts of the corresponding acid chloride (Supplementary Scheme 1) . The synthesis of the N-acyl-3-chloro-L-Tyrosine derivatives 9a-e commenced with the selective monochlorination of L-tyrosine with sulfuryl chloride, delivering the hydrochloride salt 8 in good yield (23) . Subsequent N-acylation of 8 was accomplished by two different procedures (Supplementary Scheme 2). In the first procedure an excess of Nethyldiisopropylamine and acid chloride and hydrolysis of possible O-acylation under basic conditions afterwards delivered 9a and 9c in moderate yields. In the second procedure an excess of hexamethyldisilazane for neutralisation of the hydrochloride 8 and in situ protection of the phenol and acid functionality and silyl deprotection under acidic conditions afterwards afforded 9b, 9c and 9e in excellent yield. The substrate specificity of the enzyme was probed using 7a-e and 9a-e analogues. HPLC-MS analysis of the reactions showed that CndG failed to catalyze conversion of the analogue compounds in comparison to the native substrate. Furthermore, no oxidative decarboxylation of either free Ltyrosine, or 3-chlro-tyrosine was seen when they were added into the reaction as analogue substrates.
Kinetic studies of the enzyme under optimal catalytic conditions with various substrate concentrations were conducted by monitoring the amount of the characteristic fragment ion of the product at each time point as described formerly. The kinetic parameters (k cat = 15.5  0.45 min -1 ; K m = 21.5  1.65 µM) (Figure 6c) were calculated from Lineweaver-Burk plots using a substrate concentration range of 5.36 µM up to 96.6 µM.
DISCUSSION
The biosynthetic pathways of secondary metabolites from myxobacteria are of significant interest, as they frequently challenge established paradigms for chain assembly on modular multienzymes, as well as revealing novel and intriguing functional group transformations (24) (25) (26) (27) (28) (29) .
Chondrochloren biosynthesis proceeds in a progressive fashion via the multimodular PKS/NRPS megasynthetase enzymes CndA-CndH. Several modification enzymes are also involved and include the halogenase CndH which catalyzes the chlorination of tyrosine, and a radical methyltransferase that furnishes the ethoxy moiety at C-2 of the compound (24) . Our previous adenylation domain specificity experiments as well as in silico analysis suggested the addition of tyrosine to the penultimate chondrochloren intermediate by the A domain of the terminal NRPS module of the gene cluster (24) . However, the formation of the functionalized styryl group of the mature compound remained elusive. We suggested a post-assembly step in the chondrochloren biosynthesis for modification of the tyrosyl group via oxidative decarboxylation of the enzyme free intermediate (Figure 1c) . The cndG gene found at the downstream margin of the biosynthetic gene cluster shows significant homology to known flavoprotein oxidases. Indeed, CndG shares sequence homology (31% identity) with FeeG. This protein is encoded in the biosynthetic cluster of a fatty acid enol ester and is predicted to be involved in decarboxylation of a long-chain N-acyltyrosine to an eneamide intermediate (17;18) . Interestingly the CndG protein shows no significant sequence homology to any of the decarboxylases involved in ribosomaly biosynthesized polypeptides such as mersacidin or epidermin (30) (31) (32) . Nor does it display homology to enzymes implicated in the oxidative decarboxylation of barbamide (33) . In order to investigate the function of CndG in the biosynthetic process, a cndG mutant in the native Cm c5 strain was generated. As cndG inactivation resulted in no bacterial growth limitation in comparison to the wild type, we can exclude the possibility of pleiotropic effects resulting from integration of the inactivation plasmid. HPLC analysis of the cndG mutant in comparison to the wild type showed a complete loss of chondrochlorens ( figure 2c and 2d) , and confirmed the requirement CndG for the compound's biosynthesis. As CndG inactivation hampered the formation of chondrochlorens, new compounds (3, 4, 5 and 6) with a +46 mass shift (Figure 3a-d ) appeared in the mutant extracts. Structure elucidation of purified 4, by 2D NMR, indicated the presence of a new carboxyl group, suggesting that 4 is a carboxylated biosynthetic intermediate of chondrochloren B. This finding shows that the decarboxylation and the oxidation reactions are carried out on the prechondrochloren as final steps in their biosynthesis (Figure 1c) . However, it was unclear whether both catalytic steps are performed via CndG. To address this question, CndG was purified and characterized in vitro. This experiment showed that the enzyme successfully decarboxylated and oxidized prechondrochloren, thus producing the styryl moiety of the mature chondrochlorens ( Figure 5 ). Sequence analysis of CndG revealed several conserved residues at the N-terminal region of the protein which are characteristic of FAD binding sites (Supplementary Figure 1) . This theory was supported by the identification of FAD in the supernatant of denatured CndG. Our data show decarboxylation of the chondrochloren intermediate 4 directly after introduction of the CndG enzyme to the assay, even without addition of external FAD. In addition, we observed an increase of CndG catalytic activity upon addition of FAD to the reaction mixture. This increase in enzyme activity could by explained by a partial loss of FAD during purification of the enzyme. Similar results were described for the decarboxylase of the ribosomaly synthesized lantibiotic, mersacidin; the authors suggested loose binding of the cofactor to the enzyme cavity (10) . Moreover, a slight inhibition in the CndG reaction resulted from the addition of FMN into the assay. This may indicate a weak binding competition between FAD and the non specific FMN cofactor within the cofactor cavity site of the enzyme. No inhibition of CndG activity was observed in the presence of ion chelators, and addition of external metal ions into the reaction also had no effect. This suggests that metal ions are not required for catalytic activity of the enzyme. Based on these results, CndG can be categorized within the 'organic-cofactor' class of decarboxylases. Our data show that the CndG reaction requires molecular oxygen for oxidative decarboxylation of the pre-chondrochloren. The weak decarboxylase activity observed for chondrochloren A under the same conditions might result from imperfect "anaerobic" conditions ( Figure 6a ). Although the measured k cat for CndG is relatively low (15.5 min -1 ), rates for the biosynthesis by PKS (34;35) and NRPS (36) (37) (38) in vitro (k cat values typically in the 0.1-10 min -1 range are nearly of the same magnitude, making it unlikely that this step would be rate-limiting for the complete biosynthesis. In addition, we assume that the enzyme has been adapted to the slow growth of the bacteria, as generation times tend to be longer than 7 h. Our data also reveal that the enzyme is unable to decarboxylate a number of chlorinated and non chlorinated analogue substrates containing variable N-acyl chains. Similarly, no decarboxylation of free tyrosine or 3-chloro-tyrosine was catalyzed by CndG. These observations suggest that the acyl chain is crucial for substrate binding within the catalytic pocket, and indicates a limitation for diverse substrate recognition. Lower catalytic activity of the NusA-tagged or GST-tagged-protein demonstrates that the specific tags might influence the structural conformation of the enzyme, which may negatively affect the degree of either substrate or co-factor binding. Future work towards the elucidation of the enzyme crystal structure should shed light on the molecular basis of substrate specificity and binding center of the enzyme. These data should then allow a more detailed understanding of the CndG catalytic mechanism which is not important only for the biosynthesis of chondrochloren, but also might shed light onto the unknown chemistry behind the formation of similar moieties in other natural products.. Furthermore, an antimicrobial assay of the compound provides evidence that post-assembly modification by CndG displays a crucial role in the observed biological function of the compound, as pre-chondrochloren in contrast to chondrochloren caused no inhibition of growth of Micrococcus luteus, or Bacillus subtilis.
SIGNIFICANCE
The analysis of the chondrochloren biosynthetic pathway suggested the involvement of a set of novel tailoring transformations. Our data provides evidence for the specific function of CndG, and demonstrates that the enzyme performs the successive decarboxylation and oxidation of the functionalized pre-chondrochloren to yield the chloro-hydroxyl-styryl moiety of the compound. Therefore, CndG operates post PKS/NRPS assembly of chondrochloren and attain the biological activity to the compound. To our knowledge, this is the first example of a biochemical study on a decarboxylase that is associated with structural variation of a PKS/NRPS derived natural product. The availability of such an enzyme may enable new possibilities for combinatorial biosynthesis and enzymatic production of bioactive compounds. In addition, our data describes a new type of oxidative decarboxylation generating a styryl moiety in a natural product starting from an acylated tyrosine derivative. The finding that various genes encoding similar proteins are found in the databases suggests that the many as yet uncharacterized members of this family may perform similar functions.
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